Senior Therapeutic Area Specialist, Cardiovascular Specialty, Pensacola, FL

Pensacola, Florida, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Medical ScienceIndustries

Requirements

Candidates should possess a Bachelor’s degree in a scientific field, such as Biology, Pharmacology, or a related discipline, and have a minimum of 5 years of experience as a Therapeutic Area Specialist, preferably within the Cardiovascular specialty. Strong knowledge of cardiovascular disease, pharmacology, and clinical trial data is essential, along with demonstrated ability to build and maintain relationships with healthcare professionals.

Responsibilities

The Senior Therapeutic Area Specialist will drive demand for BMS medicines within their assigned territory, engaging with healthcare providers to articulate the clinical and scientific rationale for their use in appropriate patients. They will create and implement territory and account plans, proactively utilize tools like CE^3 to inform call plans, and provide feedback to ensure a high level of customer experience. The role also involves promoting approved indications of BMS products, maintaining scientific expertise, and collaborating with other BMS functions to deliver optimal results while exemplifying company values.

Skills

Cardiovascular disease

Pharmacology

Clinical trial data

Healthcare professionals

CE^3

Territory planning

Account planning

Customer experience

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free